文献速递类风湿关节炎

运用目标试验模拟框架改进类风湿关节炎比较效果研究:系统综述

Improving rheumatoid arthritis comparative effectiveness research through causal inference principles: systematic review using a target trial emulation framework.
PubMed 文献 · Ann Rheum Dis · 2020-05-07

该研究系统综述了31项类风湿关节炎中生物类改善病情抗风湿药的头对头比较效果研究,采用目标试验模拟框架的七个组成部分评估设计局限性。结果显示29项(94%)研究至少存在一个设计局限性,最常见于入组标准使用基线后信息、未明确因果对比类型以及未充分控制适应证混杂。目标试验模拟有助于避免这些偏倚来源。

要点

  • 94%的类风湿关节炎观察性比较效果研究存在至少一个目标试验模拟框架下的设计局限性。
  • 61%的研究使用基线后信息定义基线入组标准,可能导致入组偏倚。
  • 81%的研究未明确估计意向性治疗效应还是符合方案效应,42%未充分控制适应证混杂。

核心结论

  • 在类风湿关节炎观察性比较效果研究中,设计局限性普遍存在,目标试验模拟框架有助于识别和避免潜在偏倚来源。

研究设计与样本

  • 系统综述纳入31项类风湿关节炎中生物类改善病情抗风湿药的头对头比较效果研究,按目标试验模拟框架的七个组成部分评估设计局限性。

主要发现

  • 31项研究中29项(94%)至少存在一个设计局限性;19项(61%)使用基线后信息定义基线入组标准;25项(81%)未定义估计意向性治疗效应还是符合方案效应;13项(42%)未考虑适应证混杂或仅依赖统计混杂因素选择。

临床怎么用

  • 在设计类风湿关节炎观察性比较效果研究时,可参照目标试验模拟框架明确入组标准、治疗策略、分配程序、随访期、结局、因果对比和分析计划,以减少偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Target trial emulation is an intuitive design framework that encourages investigators to formulate their comparative effectiveness research (CER) question as a hypothetical randomised controlled trial (RCT). Our aim was to systematically review CER studies in rheumatoid arthritis (RA) to provide examples of design limitations that could be avoided using target trial emulation, and how these limitations might introduce bias. METHODS: We searched for head-to-head CER studies of biologic disease modifying anti-rheumatic drugs (DMARDs) in RA. Study designs were reviewed for seven components of the target trial emulation framework: eligibility criteria, treatment strategies, assignment procedures, follow-up period, outcome, causal contrasts of interest (ie, intention-to-treat (ITT) or per-protocol effect) and analysis plan. Hypothetical trials corresponding to the reported methods were assessed to identify design limitations that would have been avoided with an explicit target trial protocol. Analysis of the primary effectiveness outcome was chosen where multiple analyses were performed. RESULTS: We found 31 CER studies, of which 29 (94%) had at least one design limitation belonging to seven components. The most common limitations related to: (1) eligibility criteria: 19/31 (61%) studies used post-baseline information to define baseline eligibility; (2) causal contrasts: 25 (81%) did not define whether ITT or per-protocol effects were estimated and (3) assignment procedures: 13 (42%) studies did not account for confounding by indication or relied solely on statistical confounder selection. CONCLUSIONS: Design limitations were found in 94% of observational CER studies in RA. Target trial emulation is a structured approach for designing observational CER studies that helps to avoid potential sources of bias.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Zhao SS, Lyu H, Solomon DH, et al. Improving rheumatoid arthritis comparative effectiveness research through causal inference principles: systematic review using a target trial emulation framework. Ann Rheum Dis. 2020. PMID: 32381560. doi:10.1136/annrheumdis-2020-217200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。